Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Barrett

Showing results (11-20 of 80) with videos related to

Pageof 8
Sort By:
Oncoimmunology|May 13, 2015
Roadblocks to success for RNA CARs in solid tumorsNathan Singh, David M Barrett, Stephan A Grupp
Journal of Immunology (Baltimore, Md. : 1950)|July 19, 2015
Chimeric Antigen Receptor- and TCR-Modified T Cells Enter Main Street and Wall StreetDavid M Barrett, Stephan A Grupp, Carl H June
Immunological Reviews|July 30, 2019
Cellular therapy: Immune-related complicationsJoseph H Oved, David M Barrett, David T Teachey
Journal of Cancer Immunology|August 8, 2022
High Expression of TIM 3 and Galectin 9 on Immunohistochemistry Staining of Tumor Specimen at Diagnosis in Pediatric Patients with Ewing SarcomaStephanie J Si, Gerald B Wertheim, David M Barrett
Current Opinion in Pediatrics|December 24, 2013
Toxicity management for patients receiving novel T-cell engaging therapiesDavid M Barrett, David T Teachey, Stephan A Grupp
The Journal of Urology|September 8, 2005
Photoselective potassium-titanyl-phosphate laser vaporization of the benign obstructive prostate: observations on long-term outcomesReza S Malek, Randall S Kuntzman, David M Barrett
Science Translational Medicine|January 8, 2016
Early memory phenotypes drive T cell proliferation in patients with pediatric malignanciesNathan Singh, Jessica Perazzelli, Stephan A Grupp, et al.
Cytotherapy|July 6, 2020
Thoracic duct lymphatic fluid harbors phenotypically naive T cells for use in adoptive T-cell therapyJessica B Foster, Yoav Dori, Stephan A Grupp, et al.
Cancer Discovery|January 12, 2019
Naïve T-cell Deficits at Diagnosis and after Chemotherapy Impair Cell Therapy Potential in Pediatric CancersRajat K Das, Lauren Vernau, Stephan A Grupp, et al.
Cancer Journal (Sudbury, Mass.)|March 22, 2021
Improving and Maintaining Responses in Pediatric B-Cell Acute Lymphoblastic Leukemia Chimeric Antigen Receptor-T Cell TherapyRahul Arya, David M Barrett, Stephan A Grupp, et al.
Pageof 8

Showing results (11-20 of 80) with videos related to

Sort By:
Pageof 8
Oncoimmunology|May 13, 2015
Roadblocks to success for RNA CARs in solid tumorsNathan Singh, David M Barrett, Stephan A Grupp
Journal of Immunology (Baltimore, Md. : 1950)|July 19, 2015
Chimeric Antigen Receptor- and TCR-Modified T Cells Enter Main Street and Wall StreetDavid M Barrett, Stephan A Grupp, Carl H June
Immunological Reviews|July 30, 2019
Cellular therapy: Immune-related complicationsJoseph H Oved, David M Barrett, David T Teachey
Journal of Cancer Immunology|August 8, 2022
High Expression of TIM 3 and Galectin 9 on Immunohistochemistry Staining of Tumor Specimen at Diagnosis in Pediatric Patients with Ewing SarcomaStephanie J Si, Gerald B Wertheim, David M Barrett
Current Opinion in Pediatrics|December 24, 2013
Toxicity management for patients receiving novel T-cell engaging therapiesDavid M Barrett, David T Teachey, Stephan A Grupp
The Journal of Urology|September 8, 2005
Photoselective potassium-titanyl-phosphate laser vaporization of the benign obstructive prostate: observations on long-term outcomesReza S Malek, Randall S Kuntzman, David M Barrett
Science Translational Medicine|January 8, 2016
Early memory phenotypes drive T cell proliferation in patients with pediatric malignanciesNathan Singh, Jessica Perazzelli, Stephan A Grupp, et al.
Cytotherapy|July 6, 2020
Thoracic duct lymphatic fluid harbors phenotypically naive T cells for use in adoptive T-cell therapyJessica B Foster, Yoav Dori, Stephan A Grupp, et al.
Cancer Discovery|January 12, 2019
Naïve T-cell Deficits at Diagnosis and after Chemotherapy Impair Cell Therapy Potential in Pediatric CancersRajat K Das, Lauren Vernau, Stephan A Grupp, et al.
Cancer Journal (Sudbury, Mass.)|March 22, 2021
Improving and Maintaining Responses in Pediatric B-Cell Acute Lymphoblastic Leukemia Chimeric Antigen Receptor-T Cell TherapyRahul Arya, David M Barrett, Stephan A Grupp, et al.
Pageof 8